Liquidia Corporation
LQDA$686M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMORRISVILLE170 employees
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LQDA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
LIQ861 Inhaled Treprostinil
Primary Pulmonary Hypertension
L606
Pulmonary Hypertension Due to Lung Disease (Disorder)
Fluzone® (2010/2011 Inactivated Trivalent Influenza Vaccine)
Influenza
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LIQ861 Inhaled Treprostinil | Phase 3 | Primary Pulmonary Hypertension | - | - |
L606 | Phase 3 | Pulmonary Hypertension Due to Lung Disease (Disorder) | - | - |
Fluzone® (2010/2011 Inactivated Trivalent Influenza Vaccine) | Phase 2 | Influenza | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply